Table 4.
Summary of polysaccharides biopolymer used for fabrication of redox-responsive delivery systems
| Structure | nanocarrier | Biopolymers | Hydrophobic | |
|---|---|---|---|---|
| HA-SS-CUR | Micelle | Hyaluronic acid | CUR | (93, 94) |
| HA-SS-PLA/ TPGS/PTX | Micelle | Hyaluronic acid | Poly(lactide)/ TPGS/ PTX | (95) |
| AlPcS2a –PEG- HA-SS- / Arg-PEA/DOX | nanocomplex | Hyaluronic acid/ polyethylene glycol | Arginine based poly(ester amide) | (98) |
| TOS-SS-SAL/ HA-TOS/pTX | nanoparticles | Hyaluronic acid | TOS | (96) |
| HCS/DOX | Micelle | Hyaluronic acid | g-stearic acid | (97) |
| GA-HA-SS-Cur/ DSPE-PEG/CUR | nano-echinus | Hyaluronic acid | glycyrrhetic acid /1,2-Distearoylphosphatidylethanolamine / CUR | (59) |
| Chito-SeSe-PEG | Nanocomposit | Chitosan | (83) | |
| HA(HECS-SS-OA)/GA | Micelle | Chitosan/ hyaluronic acid | Octylamine/GA | (57) |
| CS-SS-RA/PTX | Micelle | Chitosan | Retinoic acid/PTX | (60) |
| HS-SS-VES/DOX | Micelle | Heparan sulfate | Vitamin E succinate/DOX | (99) |
| Chol -LMWH- LA | nanoparticles | Low molecular weight heparin | Cholesterol / lipoic acid | (100) |
| CS-R(HA-R) | Micelle | Chondroitin sulfate or hyaluronic acid | Alkane | (101) |
| ALN-HA-SS-L-L/DOX | Liposomes | Hyaluronic acid/ PEG | Alendronate (ALN) DSPE/ liposome/ DOX | (58) |
| FMSN-SS-PNA (Cy5) | MSN | peptid | MSN | (69) |
| DOX@MSN-SS-CD/ azobenzene/galactose | MSN | β- cyclodextrin | MSN /DOX | (103) |